June 12, 2008 – The registry arm of a clinical study to assess the safety and effectiveness of Cook Medical’s Zilver PTX Drug-Eluting Peripheral Stent (DES) in treating peripheral arterial disease (PAD) has yielded positive interim results, trial investigators reported at the 2008 SVS Vascular Annual Meeting last week.

June 12, 2008 – In its post-congress report, the Association of periOperative Registered Nurses (AORN) 55th annual congress in Anaheim, CA drew 6,445 nurse registrants.

AORN said this is up 2.9 percent from the 6,261 who attended the 2007 Congress in Orlando, FL. This year 611 companies were represented on the exhibit floor.

Congress 2008 Attendees by type:
3,087 Managers
593 Educators
160 Students
379 Other/Unidentified
2,078 Staff Nurse
349 Exhibit Floor Only

June 12, 2008 - St. Mary’s Medical Center (SMMC) is one of the first hospitals on the West Coast to routinely use the SPY Intraoperative imaging system (SPY or SPY System) in cardiothoracic procedures surgeries to confirm placement of bypass grafts.

June 12, 2008 - Sorin Group closed the sale of its peripheral stent business to Datascope Corp., divesting its noncore assets in order to better focus on its strategic businesses, cardiopulmonary, heart valves and CRM.

Sorin's peripheral stent products are dedicated to the treatment of peripheral arterial disease ("PAD") and use the Carbofilm Technology, whose excellent biocompatible and hemocompatible characteristics are clinically well proven.

June 11, 2008 - TraumaCure Inc. said last week the DOD Joint Committee on Tactical Combat Casualty Care (CoTCCC) recommended U.S. soldiers from all services carry the company’s hemostatic agent, WoundStat.

The CoTCCC based its recommendations on the results of extensive studies conducted by both the army’s Institute for Surgical Research (ISR) and the Naval Medical Research Center (NMRC). In those studies, no other product was as effective across the board in terms of survival, post treatment blood loss, and duration of hemostasis.

Researchers are using speckle tracking imaging in heart ultrasound to monitor the health of transplant acceptance, and clinicians are redefining how to predict and classify the risk of a heart attack among women. These are some of the hot topics being presented at the 19th Annual Scientific Sessions of the American Society of Echocardiography (ASE), June 7-11, in Toronto.

June 10, 2008 - The use of ultrasound contrast agents during stress echocardiograms is safe, according to results presented at the 19th Annual Scientific Sessions of the American Society of Echocardiography.

These findings are significant after the FDA mandated a black box warning on labels of contrast agents used for cardiovascular ultrasound.

June 10, 2008 – A new calcium scoring method, which takes into account not only the amount of calcified plaque build-up in the coronary arteries but also its distribution, may better predict a person’s risk of heart attack, according to a new multicenter study published in the June issue of the journal Radiology.

June 10, 2008 - OrbusNeich received CE Mark approval for the Scoreflex coronary dilatation catheter, a new product that extends OrbusNeich's balloon catheter portfolio.

Scoreflex is designed for use in focused force angioplasty, a technique in which the force resulting from balloon inflation in a stenotic lesion is concentrated at one or more locations within the stenosis. Published research has shown that focused force angioplasty is effective in resolving resistant stenosis, while reducing the frequency of complications with its use of gradual, low-pressure inflations.

OrbusNeich's Scoreflex coronary dilatation catheter, which is only CE Mark approval, but not yet FDA cleared, is a new product that extends OrbusNeich's balloon catheter portfolio.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now